NCT01839838View on ClinicalTrials.gov

APBI Proton Feasibility and Phase II Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 22, 2013

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions
Stage IA-IIA Breast Cancer
Interventions
RADIATION

Proton Therapy

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01839838 - APBI Proton Feasibility and Phase II Study | Biotech Hunter | Biotech Hunter